Therapy Areas
27 March 2026 - Clinical-stage biopharmaceutical company Hoth Therapeutics Inc (NASDAQ:HOTH) announced on Thursday that it has deployed OpenClaw, an advanced AI-enabled computational platform designed to accelerate drug discovery, improve data-driven...
27 March 2026 - Insilico Medicine (HK:3696), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, and Tenacia Biotechnology (Hong Kong) Co Limited, a China-based, commercial-stage biopharmaceutical company focused on...
27 March 2026 - Japanese pharmaceutical company Eisai Co Ltd (TYO:4523) and US-based oncology company Nuvation Bio Inc (NYSE:NUVB) announced on Thursday that the European Medicines Agency (EMA) has validated the Marketing Authorisation Application (M...
27 March 2026 - Danish pharmaceutical company Novo Nordisk A/S (CPH:NOVO-B) (NYSE:NVO) announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for Awiqli (insulin icodec-abae) injection 700 units/mL, the fir...
26 March 2026 - Clinical-stage biopharmaceutical company Iterion Therapeutics reported on Wednesday that the first patient has been dosed at HonorHealth Research Institute in a phase 1/2 clinical trial evaluating tegavivint, a first-in-class, small m...